The new Third-Party Audit Report Library (3PARL®) consortium, founded by Rephine and Eurofins Healthcare, aims to set a benchmark for life sciences manufacturing supply chain…
Liquid biopsies — blood tests that provide an alternative to traditional surgical biopsies — are making it easier to detect, monitor, and treat cancer. In fact, liquid…
What are the critical next steps as the Life Sciences industry embraces a future that is data rather than document driven in its management of…
As data becomes more important than documents when it comes to regulatory submissions and operational decision-making, there is a renewed focus on data quality. Amplexor’s…
We speak to Lance Hill, CEO of Within3, about how life sciences companies should embrace the power of insights management throughout the total life-cycle of…
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
